Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,912
Total Claims
$839K
Drug Cost
405
Beneficiaries
$2,073
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,961 Nephrology providers
+62%
Cost per patient vs peers
$2,073 vs $1,283 avg
+81%
Brand preference vs peers
16.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.5%
Opioid Rate
176
Opioid Claims
$2,577
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,932 claims · $538K
Generic: 9,954 claims · $300K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 537 | $158K |
| Sitagliptin Phosphate | 107 | $30K |
| Rivaroxaban | 84 | $22K |
| Empagliflozin | 62 | $19K |
| Linaclotide | 30 | $16K |
| Dulaglutide | 33 | $16K |
| Budesonide | 53 | $12K |
| Fluticasone/Umeclidin/Vilanter | 16 | $11K |
| Potassium Chloride | 313 | $9,502 |
| Memantine Hcl/Donepezil Hcl | 34 | $9,261 |
| Atorvastatin Calcium | 512 | $8,089 |
| Sacubitril/Valsartan | 24 | $8,086 |
| Midodrine Hcl | 72 | $7,837 |
| Linagliptin | 29 | $7,645 |
| Mirabegron | 32 | $7,451 |
Prescribing Profile
Patient Profile
82
Avg Age
67%
Female
2.94
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About